Literature DB >> 22319970

Montelukast as a treatment modality for eosinophilic gastroenteritis.

N De Maeyer1, A-M Kochuyt, W Van Moerkercke, M Hiele.   

Abstract

Eosinophilic Gastroenteritis (EG) is a rare condition, caused by eosinophilic inflammatory infiltrates in the gastrointestinal tract. It is usually treated successfully with systemic glucocorticoids. Because of frequent relapses, however, there is need for alternatives. We describe a 38-year old man with steroid-dependent EG, who was successfully treated with montelukast, a leukotriene receptor antagonist. It inhibits leukotriene D4, an important cytokine in the inflammatory cascade. Although montelukast could not replace steroid therapy, it acted as a steroid sparing agent in our patient. Review of the literature shows that montelukast is efficient in the treatment of EG in a part of the patients. The low cost, the low number of side effects and its efficiency make it an interesting alternative in relapsing or steroid dependent EG. There is need for multicentric studies regarding the treatment of EG.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22319970

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  11 in total

1.  Classification of eosinophilic disorders of the small and large intestine.

Authors:  Aoife J McCarthy; Kieran Sheahan
Journal:  Virchows Arch       Date:  2017-11-10       Impact factor: 4.064

2.  Eosinophilic Gastroenteritis: An Underdiagnosed Condition.

Authors:  Tarik Alhmoud; Joshua Anspach Hanson; Gulshan Parasher
Journal:  Dig Dis Sci       Date:  2016-05-27       Impact factor: 3.199

Review 3.  Diagnosis, Natural History and Treatment of Eosinophilic Enteritis: a Review.

Authors:  Guillaume Pineton de Chambrun; Gaspard Dufour; Barbara Tassy; Benjamin Rivière; Najima Bouta; Michael Bismuth; Fabrizio Panaro; Natalie Funakoshi; Jeanne Ramos; Jean-Christophe Valats; Pierre Blanc
Journal:  Curr Gastroenterol Rep       Date:  2018-07-02

Review 4.  Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Yaaser Q Almulaiky; Natália Cruz-Martins; Gaber El-Saber Batiha
Journal:  Eur J Pharmacol       Date:  2021-05-15       Impact factor: 4.432

Review 5.  Eosinophilic gastroenteritis: Approach to diagnosis and management.

Authors:  Antoine Abou Rached; Weam El Hajj
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-11-06

Review 6.  Eosinophilic gastroenteritis with multiple serous membrane effusion as the first sign: a case report and literature review.

Authors:  Ma Liang; Zhang Liwen; Chen Bingfang; Ding Yanbo; Chen Jianping
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

Review 7.  Successful use of montelukast in eosinophilic gastroenteritis: a case report and a literature review.

Authors:  Emran A El-Alali; Ibrahim M Abukhiran; Tarik Z Alhmoud
Journal:  BMC Gastroenterol       Date:  2021-07-08       Impact factor: 3.067

Review 8.  Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function.

Authors:  A J Theron; H C Steel; G R Tintinger; C M Gravett; R Anderson; C Feldman
Journal:  J Immunol Res       Date:  2014-05-25       Impact factor: 4.818

9.  A Case of Eosinophilic Gastroenteritis with Ascites.

Authors:  Erkan Caglar; Aslı Sezgin Caglar; Suut Gokturk; Ahmet Dobrucali
Journal:  Case Rep Med       Date:  2015-12-24

10.  A Prospective Study on the Prevalence, Extent of Disease and Outcome of Eosinophilic Gastroenteritis in Patients Presenting with Lower Abdominal Symptoms.

Authors:  Chee K Hui; N Kit Hui
Journal:  Gut Liver       Date:  2018-05-15       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.